The Global Commission on Drug Policy highlights how negative perceptions of people who use drugs underpin their discrimination, and suggest avenues for political, medical and other State authorities to break the cycle of stigma.
The report argues that to face mortality rates among people who use drugs in the UK the use of drug consumption rooms is imperative, especially in light of the rise of synthetic opioids like fentanyl and carfentanil.
The draft bill introduces important changes to Myanmar drug law, including an approach based on public health instead of criminal justice, and better access to health services instead of long prison sentences for drug users.
The Commission will also organise a 12-week online public consultation (accessible via the Commission's public consultations page) allowing the wider public to share views and inputs. It will run in Spring 2018.
The proposed regulations aim to allow legal and quality-controlled products to be available by July 2018 and immediately begin to address the public health and safety risks posed by illegally-produced cannabis.